In the study by Torelli et al., conjugates of 140 nm FNDs and a single-chain version of vascular endothelial growth factor (VEGF) were used to target VEGF receptors in mammary carcinoma tumours in vitro and in vivo (induced 4T1 carcinoma in Balb/c mice) [40]. This evidence concerns the gene VEGFA and carcinoma.